Non-Invasive Prenatal Testing Market

Non-Invasive Prenatal Testing Market

Growth Factors of Non-Invasive Prenatal Testing Market

The non-invasive prenatal testing market size was valued at USD 5.20 billion in 2022, and the market is now projected to grow from USD 6.07 billion in 2023 to USD 19.09 billion by 2030, exhibiting a CAGR of 17.8% during the forecast period of 2023-2030.

The COVID-19 outbreak had a limited impact on the market due to the increased adoption of non-invasive prenatal testing (NIPT), as pregnant women avoided hospital visits for invasive procedures. NIPT provided a safer alternative for evaluating genetic risks during the pandemic. Additionally, companies maintained close communication with the U.S. FDA to mitigate potential supply chain disruptions.

The maternal age at childbearing has risen due to various social and economic factors, with the average age of U.S. women giving birth increasing from 27 to 30, according to NBC News. The CDC reports that women aged 35 or older face a higher risk of having a pregnancy affected by Down syndrome compared to younger women. These trends are linked, contributing to the growing prevalence of Down syndrome and other genetic complications in newborns.

In recent years, prenatal screening has increasingly favored non-invasive tests due to their clinical and economic advantages. The introduction of technologically advanced non-invasive testing options by market players, alongside their proven clinical effectiveness, has facilitated this shift. For example, in July 2022, Genetic Technologies Limited, an Australian company, expanded its presence in European and Indian markets by acquiring U.S.-based EasyDNA. This move reflects the growing trend toward non-invasive prenatal testing.

Comprehensive Analysis of Non-Invasive Prenatal Testing Market

The non-invasive prenatal testing market growth is also increasing exponentially because of the segmentation of its market. This market expansion rightly provides a thorough market breakdown near to the industry considering the leading supply and demand forces. These segmentations are methodically segregated by product analysis, by technology analysis, and by end-user analysis. By component analysis incudes consumables & reagents, and instruments. By technology analysis incudes next-generation sequencing (NGS), microarray, polymerase chain reaction (PCR), and rolling circular amplification. By end-user analysis incudes hospitals and clinical laboratories.

The North America region lead the non-invasive prenatal testing market share by benefitting a market size of USD 2.66 billion in 2023 due to the higher incidence of Down syndrome in newborns.

Top players in the market have their responsibility of healthcare industrial prospectus growth of the retailing industry and the markets. These players include, Illumina Inc., YOURGENE HEALTH, Natera, F. Hoffmann-La Roche Ltd, PerkinElmer Inc., Laboratory Corporation of America, Eurofins LifeCodexx GmbH these market players provide a level-playing competitive landscape.

In September 2022, YOURGENE HEALTH has been granted the approval by the Health Sciences Authority (HSA) for the IONA Nx NIPT Workflow in Singapore in its clinical laboratories.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2030

Base Year 2022

Estimated Year 2023

Forecast Period 2023-2030

Historical Period 2019-2021

Growth Rate CAGR of 17.8% from 2023-2030

Unit Value (USD billion)

Segmentation By Product, Technology, End User, and Region

By Product Consumables & Reagents

Instruments

By Technology

Next Generation Sequencing (NGS)

Microarray

Polymerase Chain Reaction (PCR)

Rolling Circular Amplification

By End User Hospitals

Clinical Laboratories

By Region North America (By Product, By Technology, By End User, and By Country)

U.S. (By Product)

Canada (By Product)

Europe (By Product, By Technology, By End User, and By Country)

U.K. (By Product)

Germany (By Product)

France (By Product)

Italy (By Product)

Spain (By Product)

Rest of Europe (By Product)

Asia Pacific (By Product, By Technology, By End User, and By Country)

China (By Product)

Japan (By Product)

India (By Product)

Australia (By Product)

Southeast Asia (By Product)

Rest of Asia Pacific (By Product)

Latin America (By Product, By Technology, By End User, and By Country)

Brazil (By Product)

Mexico (By Product)

Rest of Latin America (By Product)

Middle East & Africa (By Product, By Technology, By End User, and By Country)

GCC (By Product)

South Africa (By Product)

Rest of Middle East & Africa (By Product)